Hepatocellular carcinoma: Correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast-enhanced computed tomography

Investigative Radiology

Volumn 36, Issue 8, 2001, Pages 487-492

  Kwak, Byung Kook ^a   Shim, Hyung Jin ^a   Park, Eon Sub ^a   Kim, Soo Ah ^b   Choi, Dongil ^c   Lim, Hyo K ^c   Park, Cheol Keun ^c   Chung, Jin Wook ^d,e   Park, Jae Hyung ^d,e,f  

^a Chung Ang University College of Medicine   (South Korea)

^b Sung Ae General Hospital   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Seoul National University Biomedical Research Institute   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

Author keywords

Blood supply; Computed tomography; Contrast enhancement; Helical; Hepatocellular carcinoma; Liver computed tomography; Liver neoplasms; Vascular endothelial growth factor

Indexed keywords

ANTIBODY; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION FUNCTION; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR VOLUME;

EID: 0034876052     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200108000-00008     Document Type: Article

References (37)

1. Characterization of focal hepatic tumors: Value of two-phase scanning with spiral computed tomography
2. Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT
3. Hepatic lesion characterization in cirrhosis: Significance of arterial hypervascularity on dual-phase helical CT
4. Pharmacokinetics of contrast media
5. Relations between chemical structure, animal toxicity and clinical adverse effects of contrast media
6. Pathophysiologic basis of contrast enhancement in breast tumors
7. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
8. Fast MRI contrast medium dynamics for characterization of tumors: Experiences with functional MR-mammography
9. Dynamic contrast enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors
10. Vascular permeability factor: A unique regulator of blood vessel function
11. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
12. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
13. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
14. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
15. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma
16. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
17. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma
18. Expression of vascular endothelial growth factor in human hepatocellular carcinoma
19. Purification of a vascular permeability factor (VPF) from tumor cell conditioned medium
20. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor
21. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
22. Distinct biologic activities of different angiogenic molecules
23. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
24. Conceptual review of the hepatic vascular bed
25. Understanding and optimizing use of contrast material for CT of the liver
26. Hepatic CT of the liver: Value of an early hepatic arterial phase
27. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
28. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
29. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
30. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
31. Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors
32. Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma
33. Contrast enhancement of focal hepatic lesions in CT: Effect of size and histology
34. Hepatocellular carcinoma: Correlation of CT, angiographic, and histopathologic findings
35. Small hepatocellular carcinoma: Two-phase dynamic incremental CT in detection and evaluation
36. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: Evaluation by CT during intra-arterial injection of contrast medium
37. Hepatocellular carcinoma: Correlation between gadobenate dimeglumine-enhanced MR1 and pathological finding